Atlas Trials

The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma

Clinical trial NCT04695366 · COMPLETED

Trial details

NCT number
NCT04695366
Sponsor
Herlev Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Diffuse Large B Cell LymphomaPatient Reported Outcome
Start date
2021-02-10
Primary completion
2023-04-30
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.